Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis.
暂无分享,去创建一个
Jean-Pierre Devogelaer | Andrea Laslop | Jean-Yves Reginster | Eric Abadie | J. Reginster | O. Bruyère | A. Laslop | G. Herrero-Beaumont | L. V. D. van de Putte | J. Branco | L. Vanhaelst | A. Kahan | E. Abadie | J. Devogelaer | G. Nuki | G. Bouvenot | B. Avouac | Olivier Bruyere | Gabriel Herrero-Beaumont | Jaime Branco | George Nuki | Dominique Ethgen | Bernard Avouac | Gilles Bouvenot | Gonzalo Calvo | Renee Lilianee Dreiser | Andre Kahan | Godfried Kreutz | Ernst Martin Lemmel | Leo Van De Putte | Luc Vanhaelst | G. Calvo | R. Dreiser | G. Kreutz | E. Lemmel | D. Ethgen | L. van de Putte
[1] M. Dougados,et al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. , 2001, Arthritis and rheumatism.
[2] D. Felson,et al. Meniscal subluxation: association with osteoarthritis and joint space narrowing. , 1999, Osteoarthritis and cartilage.
[3] M. Dougados,et al. Assessment of progression in knee osteoarthritis: results of a 1 year study comparing arthroscopy and MRI. , 2003, Osteoarthritis and cartilage.
[4] J. Reginster,et al. The prevalence and burden of arthritis. , 2002, Rheumatology.
[5] K. Brandt,et al. Detection of radiographic joint space narrowing in subjects with knee osteoarthritis: longitudinal comparison of the metatarsophalangeal and semiflexed anteroposterior views. , 2003, Arthritis and rheumatism.
[6] F. Cicuttini,et al. Comparison of tibial cartilage volume and radiologic grade of the tibiofemoral joint. , 2003, Arthritis and rheumatism.
[7] E. Vignon,et al. Which is the best radiographic protocol for a clinical trial of a structure modifying drug in patients with knee osteoarthritis? , 2002, The Journal of rheumatology.
[8] M. Dougados,et al. Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. , 2003, The Journal of rheumatology.
[9] D. Burstein,et al. Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI , 1999, Magnetic resonance in medicine.
[10] T J Mosher,et al. Human articular cartilage: influence of aging and early symptomatic degeneration on the spatial variation of T2--preliminary findings at 3 T. , 2000, Radiology.
[11] M. Dougados,et al. Measurement of the radiological hip joint space width. An evaluation of various methods of measurement. , 2001, Osteoarthritis and cartilage.
[12] Trevor Hastie,et al. Risk factors for progressive cartilage loss in the knee: a longitudinal magnetic resonance imaging study in forty-three patients. , 2002, Arthritis and rheumatism.
[13] Sharmila Majumdar,et al. Osteoarthritis: MR imaging findings in different stages of disease and correlation with clinical findings. , 2003, Radiology.
[14] M. Dougados,et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. , 2002, Arthritis and rheumatism.
[15] T. Cawston,et al. Markers of joint destruction: principles, problems, and potential , 2001, Annals of the rheumatic diseases.
[16] J Duryea,et al. Automated measurement of radiographic hip joint-space width. , 2001, Medical physics.
[17] P A Dieppe,et al. No loss of cartilage volume over three years in patients with knee osteoarthritis as assessed by magnetic resonance imaging. , 2002, Osteoarthritis and cartilage.
[18] Juan Carlos Espinosa,et al. Comprehensive Meta-Analysis , 2004 .
[19] M. Yaron,et al. Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group. , 2000, Arthritis and rheumatism.
[20] Carl Johan Tiderius,et al. Delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) in early knee osteoarthritis , 2003, Magnetic resonance in medicine.
[21] A. Poole. Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis? , 2002, Arthritis and rheumatism.
[22] K. Pavelka,et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. , 2002, Archives of internal medicine.
[23] C. Glüer,et al. Detection of changes in cartilage water content using MRI T2-mapping in vivo. , 2002, Osteoarthritis and cartilage.
[24] Eric Lejeune,et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial , 2001, The Lancet.
[25] J Silvennoinen,et al. T2 relaxation reveals spatial collagen architecture in articular cartilage: A comparative quantitative MRI and polarized light microscopic study , 2001, Magnetic resonance in medicine.
[26] T. Spector,et al. Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section. , 1996, Annals of the rheumatic diseases.
[27] P. Garnero. Osteoarthritis: biological markers for the future? , 2002, Joint, bone, spine : revue du rhumatisme.
[28] Olivier Ethgen,et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. , 2003, The Journal of rheumatology.
[29] J. Reginster,et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. , 2003, Archives of internal medicine.
[30] M. Hochberg,et al. Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. , 2003, Osteoarthritis and cartilage.
[31] C. Peterfy,et al. Imaging of the disease process , 2002, Current opinion in rheumatology.
[32] A. Borthakur,et al. Proton spin‐lock ratio imaging for quantitation of glycosaminoglycans in articular cartilage , 2003, Journal of magnetic resonance imaging : JMRI.